Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study
Titel:
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study
Auteur:
Conteduca, V. Wetterskog, D. Sharabiani, M.T.A. Grande, E. Fernandez-Perez, M.P. Jayaram, A. Salvi, S. Castellano, D. Romanel, A. Lolli, C. Casadio, V. Gurioli, G. Amadori, D. Font, A. Vazquez-Estevez, S. González del Alba, A. Mellado, B. Fernandez-Calvo, O. Méndez-Vidal, M.J. Climent, M.A. Duran, I. Gallardo, E. Rodriguez, A. Santander, C. Sáez, M.I. Puente, J. Gasi Tandefelt, D. Wingate, A. Dearnaley, D. Demichelis, F. De Giorgi, U. Gonzalez-Billalabeitia, E. Attard, G.